Literature DB >> 27928926

Clinical observation of adverse drug reactions to non-ionic iodinated contrast media in population with underlying diseases and risk factors.

Xue Li1,2, Heng Liu1, Li Zhao1, Junling Liu1, Li Cai1, Lei Liu3, Weiguo Zhang1,2.   

Abstract

OBJECTIVE: To determine the adverse drug reaction (ADR) profile of non-ionic iodinated contrast media in populations with underlying diseases and risk factors and to provide guidance for more safe and rational use of iodinated contrast media (ICMs) in the clinic.
METHODS: Data from 120,822 cases who underwent enhanced CT examination in our hospital from January 2014 to March 2016 were collected. A standardized case report form was used for data collection and analysis.
RESULTS: The incidence of ADRs was 0.4% and 0.44% in patients with and without underlying diseases, respectively (p = 0.378). Risk factor analysis revealed that patients with asthma had the highest incidence of ADRs, followed by patients with cardiac insufficiency and patients who were aged had the lowest incidence. There was a low incidence of ADRs in patients under metformin (0.36%) and β-adrenaline receptor antagonist (0.20%) medication. The incidence was the highest in patients with previous ADRs to ICMs (7.17%) and the lowest in those with a history of ICM usage but no previous reactions (0.32%). ADRs were more common in patients at high risk at a higher injection dose (≥100 ml; p < 0.01) and speed (≥5 ml s-1; p < 0.01).
CONCLUSION: The incidence of ADRs was extremely low in patients regardless of underlying diseases. Some high-risk factors have certain correlations with the occurrence of ADRs. Particular attention should be given to patients at high risk when performing enhanced CT examination. Advances in knowledge: The correlation between various risk factors and underlying diseases and ADRs was comprehensively analyzed in a large-scale population.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27928926      PMCID: PMC5685114          DOI: 10.1259/bjr.20160729

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  21 in total

Review 1.  Adverse reactions to intravenous iodinated contrast media: a primer for radiologists.

Authors:  Saravanan Namasivayam; Mannudeep K Kalra; William E Torres; William C Small
Journal:  Emerg Radiol       Date:  2006-05-11

2.  Clinical observation of the adverse drug reactions caused by non-ionic iodinated contrast media: results from 109,255 cases who underwent enhanced CT examination in Chongqing, China.

Authors:  X Li; J Chen; L Zhang; H Liu; S Wang; X Chen; J Fang; S Wang; W Zhang
Journal:  Br J Radiol       Date:  2015-01-13       Impact factor: 3.039

Review 3.  European Society of Urogenital Radiology guidelines on contrast media application.

Authors:  Henrik S Thomsen
Journal:  Curr Opin Urol       Date:  2007-01       Impact factor: 2.309

4.  Safety of iobitridol in the general population and at-risk patients.

Authors:  Thomas J Vogl; Elmar Honold; Michael Wolf; H Mohajeri; R Hammerstingl
Journal:  Eur Radiol       Date:  2006-01-21       Impact factor: 5.315

5.  Contrast-induced nephropathy after a second contrast exposure.

Authors:  Hariprasad Trivedi; W Dennis Foley
Journal:  Ren Fail       Date:  2010       Impact factor: 2.606

6.  Frequently asked questions: iodinated contrast agents.

Authors:  Michael A Bettmann
Journal:  Radiographics       Date:  2004-10       Impact factor: 5.333

Review 7.  Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis.

Authors:  Qasim Ali Rao; Jeffrey H Newhouse
Journal:  Radiology       Date:  2006-03-16       Impact factor: 11.105

8.  Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients.

Authors:  A F Kopp; K J Mortele; Y D Cho; P Palkowitsch; M A Bettmann; C D Claussen
Journal:  Acta Radiol       Date:  2008-10       Impact factor: 1.990

9.  Post-marketing surveillance study with iodixanol in 20 185 Chinese patients from routine clinical practices.

Authors:  B-C Zhang; L Hou; B Lv; Y-W Xu
Journal:  Br J Radiol       Date:  2013-12-19       Impact factor: 3.039

10.  The Incidence, Classification, and Management of Acute Adverse Reactions to the Low-Osmolar Iodinated Contrast Media Isovue and Ultravist in Contrast-Enhanced Computed Tomography Scanning.

Authors:  Bin Zhang; Yuhao Dong; Long Liang; Zhouyang Lian; Jing Liu; Xiaoning Luo; Wenbo Chen; Xinyu Li; Changhong Liang; Shuixing Zhang
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

View more
  9 in total

Review 1.  Current Epidemiology and Management of Radiocontrast-Associated Acute- and Delayed-Onset Hypersensitivity: A Review of the Literature.

Authors:  Eric M Macy
Journal:  Perm J       Date:  2018

2.  Reduced iodinated contrast media dose and injection speed for CT: how much does this decrease the risk of a hypersensitivity reactions?

Authors:  Knut Brockow
Journal:  Quant Imaging Med Surg       Date:  2020-02

Review 3.  Hypersensitivity Reactions to Iodinated Contrast Media.

Authors:  Tsu-Man Chiu; Sung-Yu Chu
Journal:  Biomedicines       Date:  2022-04-30

Review 4.  Preprocedural fasting for contrast-enhanced CT: when experience meets evidence.

Authors:  Heng Liu; Yu Liu; Li Zhao; Xue Li; Weiguo Zhang
Journal:  Insights Imaging       Date:  2021-12-04

5.  Change the preprocedural fasting policy for contrast-enhanced CT: results of 127,200 cases.

Authors:  Heng Liu; Li Zhao; Junling Liu; Fang Lan; Li Cai; Jingqin Fang; Xue Li
Journal:  Insights Imaging       Date:  2022-02-24

Review 6.  Acute Urticaria and Anaphylaxis: Differences and Similarities in Clinical Management.

Authors:  Luis Felipe Ensina; Taek Ki Min; Mara Morelo Rocha Félix; Carolina Tavares de Alcântara; Célia Costa
Journal:  Front Allergy       Date:  2022-04-15

7.  Hypersensitivity reactions to iodinated radiocontrast media: Cluster analysis reveals distinct clinical phenotypes.

Authors:  Witchaya Srisuwatchari; Tram Vo; Amélie Gauthier; Nicolas Molinari; Rik Schrijvers; Pascal Demoly; Anca Mirela Chiriac
Journal:  World Allergy Organ J       Date:  2022-08-27       Impact factor: 5.516

8.  Low dose contrast media in step-and-shoot coronary angiography with third-generation dual-source computed tomography: feasibility of using 30 mL of contrast media in patients with body surface area <1.7 m2.

Authors:  Liang Jin; Bing Jie; Yiyi Gao; An'qi Jiang; Tingwen Weng; Ming Li
Journal:  Quant Imaging Med Surg       Date:  2021-06

9.  Incidence and Risk Factors of Nausea and Vomiting after Exposure to Low-Osmolality Iodinated Contrast Media in Children: A Focus on Preparative Fasting.

Authors:  Ji Young Ha; Young Hun Choi; Yeon Jin Cho; Seunghyun Lee; Seul Bi Lee; Gayoung Choi; Jung Eun Cheon; Woo Sun Kim
Journal:  Korean J Radiol       Date:  2020-08-04       Impact factor: 3.500

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.